Exclusive

Publication

Byline

Location

US Patent Issued to LYNK PHARMACEUTICALS on April 7 for "Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,253, issued on April 7, was assigned to LYNK PHARMACEUTICALS Co. LTD. (Hangzhou, China). "Benzamides of pyrazolylamino-pyrimidinyl derivati... Read More


US Patent Issued to CRYSTAL PHARMACEUTICAL (SUZHOU) on April 7 for "Crystal form of Resmetirom, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,254, issued on April 7, was assigned to CRYSTAL PHARMACEUTICAL (SUZHOU) Co. LTD. (Suzhou, China). "Crystal form of Resmetirom, preparation ... Read More


US Patent Issued to Hoffmann-La Roche on April 7 for "Heteroaryl-substituted imidazole derivatives" (Chinese, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,255, issued on April 7, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Heteroaryl-substituted imidazole derivatives" was inv... Read More


US Patent Issued to Merck Patent on April 7 for "Composition for organic electronic devices" (German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,256, issued on April 7, was assigned to Merck Patent GmbH (Darmstadt, Germany). "Composition for organic electronic devices" was invented b... Read More


US Patent Issued to LG DISPLAY, LT MATERIALS on April 7 for "Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,257, issued on April 7, was assigned to LG DISPLAY Co. LTD. (Seoul, South Korea) and LT MATERIALS Co. LTD. (Yongin-si, South Korea). "Heter... Read More


US Patent Issued to Tolremo Therapeutics on April 7 for "Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer" (Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,258, issued on April 7, was assigned to Tolremo Therapeutics AG (Muttenz, Switzerland). "Heterocyclic derivatives, pharmaceutical compositi... Read More


US Patent Issued to ZHUHAI UNITED LABORATORIES on April 7 for "Aminopyridine compound" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,259, issued on April 7, was assigned to ZHUHAI UNITED LABORATORIES Co. LTD. (Guangdong, China). "Aminopyridine compound" was invented by Pe... Read More


US Patent Issued to RISEN (SUZHOU) PHARMA TECH, SHANGHAI JUNSHI BIOSCIENCES on April 7 for "Stable heavy isotopes in amide functional groups and uses thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,260, issued on April 7, was assigned to RISEN (SUZHOU) PHARMA TECH Co. LTD. (Suzhou, China) and SHANGHAI JUNSHI BIOSCIENCES Co. LTD. (Shangh... Read More


US Patent Issued to BEIJING TIDE PHARMACEUTICAL on April 7 for "P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,261, issued on April 7, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing). "P2X3 and/or P2X2/3 receptor antagonist, pharmaceut... Read More


US Patent Issued to Merck Sharp & Dohme on April 7 for "PRMT5 inhibitors" (Canadian, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,262, issued on April 7, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "PRMT5 inhibitors" was invented by Michelle Machacek (Bosto... Read More